1941. Follow-on rifaximin for the prevention of recurrence following standard treatment of infection with Clostridium difficile: a competing risks analysis provides a full picture of possible treatment effects.1944. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction.
作者: Joeri Tulkens.;Glenn Vergauwen.;Jan Van Deun.;Edward Geeurickx.;Bert Dhondt.;Lien Lippens.;Marie-Angélique De Scheerder.;Ilkka Miinalainen.;Pekka Rappu.;Bruno G De Geest.;Katrien Vandecasteele.;Debby Laukens.;Linos Vandekerckhove.;Hannelore Denys.;Jo Vandesompele.;Olivier De Wever.;An Hendrix.
来源: Gut. 2020年69卷1期191-193页 |